Clinical Trials Browser

Phase 3 × INDUSTRY × HER2 Positive Early or Locally Advanced Breast Cancer × Clear all

NCT02149524 2018-10-24

A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer

Phase 3 Completed

875 enrolled 12 charts

HER2 Positive Early or Locally Advanced Breast Cancer